Pressure Builds For Revamped Acetaminophen Warnings In Rx Dispensing Materials
This article was originally published in The Pink Sheet Daily
Executive Summary
A white paper by the National Council for Prescription Drug Programs calls on industry to harmonize Rx labeling with existing labeling for OTC medicines.
You may also be interested in...
Gilenya Off And Running, But Keeping Pace Long-Range Is Key
Novartis AG's Gilenya (fingolimod) – the first oral treatment for multiple sclerosis – is off to a modestly strong start. The drug’s sales performance since its U.S. launch in October has been respectable, if not remarkable, driven by both market expansion and patient switches.
Gilenya Off And Running, But Keeping Pace Long-Range Is Key
Novartis AG's Gilenya (fingolimod) – the first oral treatment for multiple sclerosis – is off to a modestly strong start. The drug’s sales performance since its U.S. launch in October has been respectable, if not remarkable, driven by both market expansion and patient switches.
One Acetaminophen Headache Remains Untreated: Acronyms On Pharmacy Containers
FDA hopes to curtail acetaminophen overdosing by requiring manufacturers to restrict the amount of the drug in combination Rx products. But another potential cause of overdosing remains intact: the use of acronyms on pharmacy labels.